- 1BioWhy is TissueGene CEO silent about Invossa mislabeling?
- 2BioProsecutors seek arrest warrant of Samsung Bioepis executives
- 3Pharma‘Darzalex as another weapon against multiple myeloma’
- 4BioKolon desperate to keep Invossa license amid suspicion of data fabrication
- 5Pharma‘No need to reduce number of drugs for triple-drug therapy to treat HIV’
- 6HospitalResearchers find drug-resistant gene for Gleevec
- 7Policy‘Invossa scandal might be more far-reaching’